A company spokesperson said in a statement to MedTech Dive that direct causation between the deaths and calcification of the ...

Chips are one of several product types currently under Section 232 investigation by the White House, a frequent precursor to duties.

CFO Suketu Upadhyay said the company now expects a charge in 2025 of about $40 million, compared with a range of $60 million ...

Edwards Lifesciences and JenaValve said they remained committed to completing the deal and would defend the case in court.

The company said it has grown capacity by 10% this year, bringing its total U.S. output of the prefilled flush syringes to ...